Armata Pharmaceuticals, Inc.(NYSE Amex Equities : ARMP)
ARMP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||0.54%||597.62||2.6%||$505.40m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.51%||280.35||1.9%||$504.03m|
|GILD||Gilead Sciences, Inc.||0.43%||62.48||1.0%||$502.90m|
|SNSS||Sunesis Pharmaceuticals, Inc.||6.29%||3.55||0.7%||$248.16m|
|CRSP||CRISPR Therapeutics AG||-0.44%||63.00||0.6%||$166.23m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.93%||83.92||4.2%||$122.49m|
|EXAS||EXACT Sciences Corp.||-1.29%||40.58||17.7%||$95.83m|
|IOVA||Iovance Biotherapeutics, Inc.||-0.82%||10.89||0.0%||$92.14m|
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.